The Future of Cell and Gene Therapies, with E&Y’s Adlai Goldberg
Listen now
Description
Ernst & Young’s Adlai Goldberg describes the steps industry must take to advance the advanced therapy space and how it must move to balance the individualized autologous approach with more sustainable allogeneic products.
More Episodes
MilliporeSigma discusses the importance of people, education, and the benefits of embracing discomfort to bolster sustainability efforts.
This episode of our regular podcast Voices of Biotech brings you an in-depth conversation with Jeffrey Whitford, vice president of sustainability and social...
Published 04/08/24
Published 04/08/24
Samsung Biologics' James Choi discusses the CDMO’s role in teaming up with Big Pharma to tackle sustainability in the biotech space.
This episode of the Voices of Biotech – brought to you by the BioProcess Insider Expression Platform – brings you an interesting conversation with Choi about the...
Published 03/18/24
Links
Twitter
Facebook
Instagram
Patreon
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
